Yuqiang Xiao

肖玉强
CE No. BSM581 Active

This page summarises the Hong Kong Securities and Futures Commission (SFC) public register record for Yuqiang Xiao (肖玉强), a licensed Responsible Officer with CE reference BSM581. Currently licensed at 4 firm(s): ICBC International Capital Limited, ICBC International Fund Management Limited, ICBC International Securities Limited, ICBC International Futures Limited. Active regulated activities: Type 1 — Dealing in securities; Type 2 — Dealing in futures contracts; Type 4 — Advising on securities; Type 6 — Advising on corporate finance; Type 9 — Asset management. Total licence records on file: 13.

Licence history

FirmRoleRegulated activityFromTo
ICBC International Capital Limited
工銀國際融資有限公司
RO Type 1 — Dealing in securities 2022-08-31 present
ICBC International Fund Management Limited
工銀國際基金管理有限公司
RO Type 1 — Dealing in securities 2022-08-31 present
ICBC International Securities Limited
工銀國際證券有限公司
RO Type 1 — Dealing in securities 2022-08-31 present
ICBC International Futures Limited
工銀國際期貨有限公司
RO Type 2 — Dealing in futures contracts 2022-08-31 present
ICBC International Capital Limited
工銀國際融資有限公司
RO Type 4 — Advising on securities 2022-08-31 present
ICBC International Fund Management Limited
工銀國際基金管理有限公司
RO Type 4 — Advising on securities 2022-08-31 present
ICBC International Securities Limited
工銀國際證券有限公司
RO Type 4 — Advising on securities 2022-08-31 present
ICBC International Capital Limited
工銀國際融資有限公司
RO Type 6 — Advising on corporate finance 2022-08-31 present
ICBC International Fund Management Limited
工銀國際基金管理有限公司
RO Type 9 — Asset management 2022-08-31 present
ICBC International Asset Management Limited
工銀國際資產管理有限公司
RO Type 1 — Dealing in securities 2022-08-31 2024-03-13
ICBC International Research Limited
工銀國際證券研究有限公司
RO Type 4 — Advising on securities 2022-08-31 2024-05-02
ICBC International Asset Management Limited
工銀國際資產管理有限公司
RO Type 4 — Advising on securities 2022-08-31 2024-03-13
ICBC International Asset Management Limited
工銀國際資產管理有限公司
RO Type 9 — Asset management 2022-08-31 2024-03-13

Related